Therapeutic strategies against protein misfolding in neurodegenerative diseases

ISSN： 1746-0441

Source： Expert Opinion on Drug Discovery, Vol.4, Iss.1, 2009-01, pp. : 71-84

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Natural Animal Models of Neurodegenerative Protein Misfolding Diseases

Current Pharmaceutical Design, Vol. 18, Iss. 8, 2012-03 ,pp. : 1148-1158

Bentham Science Publishers

Access to resources Recommend Favorite

Patented therapeutic RNAi strategies for neurodegenerative diseases of the CNS

By Orlacchio Antonio Bernardi Giorgio Orlacchio Aldo Martino Sabata

Expert Opinion on Therapeutic Patents, Vol. 18, Iss. 10, 2008-10 ,pp. : 1161-1174

Informa Healthcare

Access to resources Recommend Favorite

Raf Inhibitors as Therapeutic Agents Against Neurodegenerative Diseases

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 9, Iss. 1, 2010-03 ,pp. : 120-127

Bentham Science Publishers

Access to resources Recommend Favorite

Therapeutic Approaches to Polyglutamine Diseases: Combating Protein Misfolding and Aggregation

Current Pharmaceutical Design, Vol. 12, Iss. 20, 2006-07 ,pp. : 2543-2555

Bentham Science Publishers

Access to resources Recommend Favorite

Editorial: New Avenues and Therapeutic Strategies for the Treatment of Neurodegenerative Diseases

Current Pharmaceutical Design, Vol. 23, Iss. 5, 2017-03 ,pp. : 667-668

Bentham Science Publishers

Access to resources Recommend Favorite